VaxigripTetra Suspension zur injektion in einer fertigspritze

Χώρα: Ελβετία

Γλώσσα: Γερμανικά

Πηγή: Swissmedic (Swiss Agency for Therapeutic Products)

Δραστική ουσία:

haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022), haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/9/2021 (H3N2)-like: reassortant virus IVR-228 derived from A/Darwin/9/2021), haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: B/Michigan/01/2021, wilde type (Victoria lineage))

Διαθέσιμο από:

Sanofi-Aventis (Suisse) SA

Φαρμακολογική κατηγορία (ATC):

J07BB02

INN (Διεθνής Όνομα):

haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022), haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/9/2021 (H3N2)-like: reassortant virus IVR-228 derived from A/Darwin/9/2021), haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: B/Michigan/01/2021, wilde type (Victoria lineage))

Φαρμακοτεχνική μορφή:

Suspension zur injektion in einer fertigspritze

Σύνθεση:

haemagglutininum influenzae A (H1N1) (Virus souche A/Victoria/4897/2022 (H1N1)pdm09-like: reassortant virus IVR-238 derived from A/Victoria/4897/2022) 15 µg, haemagglutininum influenzae A (H3N2) (Virus souche A/Darwin/9/2021 (H3N2)-like: reassortant virus IVR-228 derived from A/Darwin/9/2021) 15 µg, haemagglutininum influenzae B (Virus souche B/Austria/1359417/2021-like: B/Michigan/01/2021, wilde type (Victoria lineage)) 15 µg, haemagglutininum influenzae B (Virus souche B/Phuket/3073/2013-like: B/Phuket/3073/2013, wilde type (Yamagata lineage)) 15 µg, natrii chloridum, kalii chloridum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.72 mg, kalium 0.08 mg, residui: formaldehydum, octoxinolum-9, neomycinum, ovalbuminum.

Kατηγορία:

B

Θεραπευτική ομάδα:

Impfstoffe

Θεραπευτική περιοχή:

Aktive immunisierung gegen influenza, ab dem 6. monat

Καθεστώς αδειοδότησης:

zugelassen

Ημερομηνία της άδειας:

2018-12-06